RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Ampersand Biomedicines

Ampersand Biomedicines

Ampersand is enabling potent mechanisms to treat disease by creating and programming therapeutics that are more efficacious, without compromising on safety or tolerability.

Latest funding

$65M Series B+ ·

Source: fundraisingfox.com

Funding history ↓
Website: ampersand.bio.
X: @AmpersandBio · 117 followers.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Medical, Therapeutics.
Stage: Series B+.
Based in: Boston, United States.
Founded: 2021.
Last round: Mar 19, 2025 · 603 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Nov 8, 2026.

Signals

X account@AmpersandBio · created Dec 5, 2022 (3 years old) · 117 followers
Website registeredAug 16, 2022 (4 years old)
TIMELINE · MONEY RAISED

Ampersand Biomedicines | 946 days from website to first raise on record

@AmpersandBio·Raised $65M in 1 sourced round·2 signals before the first raise
$16M$33M$49M$65MSEPAPRNOVJUNJAN 2025AUGMAROCT$65M||WEBSITE CREATED · AUG 16, 2022||X ACCOUNT CREATED @AMPERSANDBIO · DEC 5, 2022$65M Series B+ · Mar 19, 2025$65M B+ · MAR '25

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

  1. Series B+ · $65M
  2. X account created
  3. Website created

Founders and team

Acquisitions

Acquired companyPriceAnnounced
AAbCheckNot disclosed publiclyDate not given

Investors

Companies like Ampersand Biomedicines

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ampersand-biomedicines (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy